Melatonin has been found to enhance anti-tumor immunity by targeting the PD-L1 expressed on macrophages through exosomes derived from gastric cancer cells, suggesting a promising application of MLT in the realm of innovative anti-tumor immunotherapies (Wang K. et al., 2023). Here, CD274 is linked to neoplasm.